Cogent Biosciences CEO Andrew Robbins' 2022 pay jumps 53% to $4.4M
Cogent Biosciences reports 2022 executive compensation
By ExecPay News
Published: April 25, 2023
Cogent Biosciences reported fiscal year 2022 executive compensation information on April 25, 2023.
In 2022, three executives at Cogent Biosciences received on average a compensation package of $2.7M, a 19% decrease compared to previous year.
Average pay of disclosed executives at Cogent Biosciences
Andrew Robbins, Chief Executive Officer, received $4.4M in total, which increased by 53% compared to 2021. 78% of Robbins' compensation, or $3.4M, was in option awards. Robbins also received $345K in bonus, $624K in salary, as well as $12K in other compensation.
Jessica Sachs, Chief Medical Officer, received a compensation package of $1.9M, which decreased by 50% compared to previous year. 65% of the compensation package, or $1.2M, was in option awards.
John Robinson, Chief Scientific Officer, earned $1.9M in 2022, a 46% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2023.